Animal Model of Barrett's Esophagus
Animal Model of Barrett's Esophagus
批准号:
6665456
负责人:
XIAOXIN Luke CHEN
金额:
$15.55万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2005-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aim of this project is to investigate the role of bile acids in the development of Barrett's esophagus (BE), and to develop an animal model for BE and esophageal adenocarcinoma (EAC). Our previous animal models, esophagoduodenal anastomosis (EDA) and esophagogastroduodenal anastomosis (EGDA), mimicked the development of EAC by introducing mixed reflux of gastric and duodenal contents into the rat esophagus. Nevertheless, the role of bile acids in the development of BE is still not clear. This project will address this issue with the following specific aims:
1. To generate rats with reflux containing different levels of bile acids, through dietary supplementation, mimicking the bile acids profile in the gastroesophageal refluxate of human BE patients. Reflux will be induced by cardioplasty in rats. These rats will be given AIN93Mbased diets containing 0.25%, 0.5%, 1% or 2% bile acids mixture that mimics the bile acids profile in the gastroesophageal refluxate of human BE patients. Trypsin (0.4 mg/ml) and lysolecithin (1 mg/ml) will also be given in drinking fluid. Four weeks later, histopathology and the bile acids profile in the esophageal mucosa will be analyzed. The pH, trypsin, lysolecithin and the bile acids profile in the esophageal and gastric contents will also be analyzed. These results will help us select two treatment conditions for the long-term study.
2. To determine the role of bile acids in the development of rat BE, and possibly EAC. Cardioplasty rats will be given AIN93M diets containing bile acids mixtures (concentrations determined in Aim 1) plus trypsin and lysolecithin in drinking fluid. The rats will be sacrificed at 10, 20, 40 and 60 weeks after surgery. The development of BE, BE with dysplasia, and possibly EAC will be analyzed and characterized.
These studies are expected to determine the effect of bile acids on the formation of BE, and lead to the development of a novel animal model of BE and EAC. Such an animal model would provide a basis for future studies on the mechanism, prevention, and therapy of BE and EAC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
-
批准号:10810414
-
项目类别:
-
资助金额:$57.33万
-
财政年份:2022
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
-
批准号:10673201
-
项目类别:
-
资助金额:$61.69万
-
财政年份:2022
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10407469
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10530998
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10851493
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
-
批准号:10850620
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2020
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
NOTCH-PAX9 signaling in alcohol-induced esophageal injury
-
批准号:10023247
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2019
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Research Infrastructure Core (RIC)
-
批准号:9977710
-
项目类别:
-
资助金额:$87.75万
-
财政年份:2017
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Research Infrastructure Core (RIC)
-
批准号:10204733
-
项目类别:
-
资助金额:$75.05万
-
财政年份:2017
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo
-
批准号:9050352
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Resource/Infrastructure Development Core
-
批准号:8068492
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Histopathology Core-Shared Resources
-
批准号:10247142
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Racial Disparity in Barrett's Esophagus
-
批准号:8068482
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Oxidative Stress in Alcohol-associated Oral Carcinogenesis
-
批准号:8123736
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Full Project 5: Mechanisms and Targeted Therapy of Nrf2high Esophageal Squamous Cell Carcinoma
-
批准号:10247148
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2010
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6640968
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:7116117
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6744836
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Chemoprevention of Tobacco-related Oral Carcinogenesis
-
批准号:6880067
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2003
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
Animal Model of Barrett's Esophagus
-
批准号:6578385
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2002
-
负责人:XIAOXIN Luke CHEN
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: